| |
|
|
|
Bridgehead International - US Expansion
continues
May 2008
Susan Garfield joins Bridgehead International
Boston office
Susan Garfield has
joined Bridgehead International as VP, Bridgehead
USA Inc. and will head up the company's Boston office.
Susan is a market access, reimbursement and economics strategist,
with an expertise in demand creation and advocacy. For over
12 years, Susan's professional career has focused on innovations
in healthcare, the economics of practice change, and the role
of reimbursement and policy to the adoption of new technologies.
Her work has included economic modelling, coding analyses
and applications, payer coverage campaigns, market strategies
for innovative technologies, health policy development, government
relations, and creating partnerships between industry and
advocacy groups.
Prior to joining
Bridgehead, Susan was Director, Global Reimbursement,
Policy and Economic Strategy at QIAGEN Corporation (formally
Digene Corporation). Before QIAGEN, Susan was a Director at
Boston Healthcare Consulting. During her tenure there, she
worked with biotechnology, medical device, pharmaceutical,
and diagnostic firms on market access strategy and execution.
In this role Susan translated primary research with over 2,000
clinicians, payers, government decision-makers and patients
into actionable programs for clients.
Susan received her
BA in English and Women's Studies from the University of Pennsylvania,
a Master's of Science in Population and Development from the
London School of Economics, and a Master's of Science in Health
Policy and Management from Harvard University, School of Public
Health. She is currently completing the Doctorate of Public
Health program at Boston University.
|
| |
|
|
Bridgehead International CEO,
Timothy Fitzgerald commented: ""We are delighted at
Susan's decision to join the team, at a time when we are pushing
ahead with a major expansion of our activities in North America.
Her expertise and experience, particularly in market access
and reimbursement, will be of real value to Bridgehead
and our clients."
Over the past four years Bridgehead's
Market Access business has grown to be the single largest
practice area in the company.
Whilst much of Bridgehead's work
on pricing, reimbursement and market access is global in nature
(US, top five Europe and Japan), the company is being increasingly
asked to use its knowledge and experience to address
US-specific issues, through:
Payer research
Therapy area scanning
Pricing strategy for commercialisation
Reimbursement negotiation strategy
Product life cycle pricing strategy
Pharmacoeconomic assessments
Health technology assessment support
|
About Bridgehead International
Bridgehead
International is a leading biopharmaceutical consultancy
group, offering a range of services designed to assist clients
in achieving extraordinary growth across the product and technology
value chain, through three practice areas:
- Market Access Solutions, including market
assessments and development of pricing and reimbursement
strategies.
- Technical and Commercial Evaluation,
covering due diligence, expert reports and decision support.
- Healthcare Education Services,
focused on specialist medical education for those working
in the pharmaceutical and biotechnology industry.
With over 50 consultants and associates
in Europe, North America and Asia, Bridgehead Consulting
provides a powerful combination of strategic, scientific,
medical, technical, commercial, economic, decision support,
modelling and intellectual property skills and experience.
|
|
Contact: +44 1664 503 700, info@bridgehead.com
or visit us at www.bridgehead.com
|
|
